European Tuberculosis Diagnosis and Treatment Market Size, Share & Trends Analysis Report by Drugs Type (First Line Drugs and Second Line Drugs) By Diagnosis (Laboratory Testing, Nucleic Acid Amplification Test, Mantoux Test, Radiography and Drug Susceptibility Testing) Forecast period (2019-2025)
European tuberculosis diagnosis and treatment market is anticipated to grow at a CAGR around 1.9% during the forecast period. There is impressive progress in the tuberculosis diagnostic and treatment in past decade, however, tuberculosis (TB) is still a public health concern in the European Region.
Countries outside of the European Union (EU) and European Economic Area (EEA) still suffer from high rates of TB and multidrug resistant (MDR) TB, while EU/EEA countries have a significant number of TB cases among vulnerable population groups, such as people of foreign origin and prisoners. TB disease affects men more than women and those gaps in case detection and reporting are higher among men.
Get Sample Copy of European Tuberculosis Diagnosis and Treatment Market at: www.omrglobal.com/request…ent-market
The key players that are active in the market include Abbott Laboratories, Becton, Dickinson and Co., BioMérieux SA, EPISTEM HOLDINGS PLC, GlaxoSmithKline PLC, Hain Lifescience GmbH, Johnson & Johnson, OTSUKA NOVEL PRODUCTS GMBH, Sandoz Inc. and Sanofi Inc.
Due to large number of TB death cases in Europe, the government are taking initiatives and including guidelines in each nation to improve the diagnostic and treatment methods across the Europe. Guidelines are predominantly available in high-income countries with established LTBI (Latent TB Infection) screening programmers.
According to World Health Organization (WHO), in 2018, A total of 1.5 million people have mortality from TB (including 251 000 people with HIV).
Across the globe, TB is one of the top 10 causes of mortality and the leading cause from a single infectious agent (above HIV/AIDS).
For More Information, get A full report of European Tuberculosis Diagnosis and Treatment Market is available at: www.omrglobal.com/industr…ent-market
European tuberculosis diagnosis and treatment market is segmented on the basis of drugs type and diagnosis. Based on drug type, the market is segmented into first line drugs and second line drugs.
Based on diagnosis, the market is segmented into laboratory testing, nucleic acid amplification test, mantoux test, radiography and drug susceptibility testing.
Market Segmentation
Tuberculosis Diagnosis and Treatment Market by Drugs Type
- First Line Drugs
- Second Line Drugs
Tuberculosis Diagnosis and Treatment Market by Diagnosis
- Laboratory Testing
- Nucleic Acid Amplification Test
- Mantoux Test
- Radiography
- Drug Susceptibility Testing
For more customized data, request for report customization @ www.omrglobal.com/report-…ent-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants.
OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit www.omrglobal.com/
News From
Orion Market Research Pvt. Ltd.Category: Market Research Publishers and RetailersCompany about: Orion Market Research (OMR) is a market research company that endeavors to provide an exclusive blend of qualitative and quantitative market research reports to global clients. The company provides syndicate, customized market research report for over 20 business domains to customers across the globe. These reports provide valuable market insights to global clients in understanding the market trends and taking crucial business decisions. The company is serving global Fortune 500 companies, …
This email address is being protected from spambots. You need JavaScript enabled to view it.
